ARCHIVES

Cetuximab Plus Irinotecan Increases PFS In Metastatic Colorectal Cancer, EPIC Finds

This article is from The Cancer Letter archive.

Vol. 30 No. 4 | April 27, 2007

Download PDF Visit The Full Archive

Related Articles

Panel Recommends 5-FU/Levamisole For Adjuvant Stage 3 Colon Cancer

April 27, 1990

Cyclamate Committee Finds No Proof Of Carcinogenicity

January 23, 1976

New Biologic Modalities Show Promise In Treatment Of Lymphomas, Research Finds

June 28, 2002

Nurses Pass Resolution To Support Research on Ethnic Patient Issues

May 29, 1992

CCIRC Disapproves NCOG Renewal, But Carter Plan Appeal To NCAB; Setback For NCI On Regional Groups

March 6, 1981

Revlimid Plus Steroid Effective In Clinical Trial

November 30, 2007